Claritin and Urogenital haemorrhage - a phase IV clinical study of FDA data


Urogenital haemorrhage is reported only by a few people who take Claritin.

The phase IV clinical study analyzes which people take Claritin and have Urogenital haemorrhage. It is created by eHealthMe based on reports of 68,430 people who have side effects while taking Claritin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

68,430 people reported to have side effects when taking Claritin.
Among them, 3 people (0.0%) have Urogenital haemorrhage.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 71,136 Claritin users for its effectiveness, alternative drugs and more.

What is Urogenital haemorrhage?

Urogenital haemorrhage (bleeding from urogenital) is found to be associated with 209 drugs and 66 conditions by eHealthMe.

Number of Claritin and Urogenital haemorrhage reports submitted per year:

Could Claritin cause Urogenital haemorrhage?

Gender of people who have Urogenital haemorrhage when taking Claritin *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who have Urogenital haemorrhage when taking Claritin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 33.33 %
  • 60+: 33.33 %

Common drugs people take besides Claritin *:

  1. Norco: 2 people, 66.67%
  2. Zofran: 1 person, 33.33%
  3. Deltasone: 1 person, 33.33%
  4. Furosemide: 1 person, 33.33%
  5. Folic Acid: 1 person, 33.33%
  6. Flomax: 1 person, 33.33%
  7. Effexor Xr: 1 person, 33.33%
  8. Diazepam: 1 person, 33.33%
  9. Demerol: 1 person, 33.33%
  10. Demadex: 1 person, 33.33%

Common side effects people have besides Urogenital haemorrhage *:

  1. Itching: 2 people, 66.67%
  2. Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 66.67%
  3. Muscle Spasms (muscle contraction): 2 people, 66.67%
  4. Chest Pain: 2 people, 66.67%
  5. Exercise Tolerance Decreased: 1 person, 33.33%
  6. Hyperkalemia (damage to or disease of the kidney): 1 person, 33.33%
  7. Herpes Zoster: 1 person, 33.33%
  8. Hepatitis C: 1 person, 33.33%
  9. Headache (pain in head): 1 person, 33.33%
  10. Haemoglobin Decreased: 1 person, 33.33%

Common conditions people have *:

  1. Stress And Anxiety: 1 person, 33.33%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 33.33%
  3. Depression: 1 person, 33.33%
  4. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and have Urogenital haemorrhage?

Check whether Urogenital haemorrhage is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Urogenital haemorrhage and when was it recovered:

Expand to all the drugs that have ingredients of loratadine:

Alternative drugs to, pros and cons of Claritin:

Common Claritin side effects:

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Urogenital haemorrhage treatments and more:

COVID vaccines that are related to Urogenital haemorrhage:

All the drugs that are associated with Urogenital haemorrhage:

All the conditions that are associated with Urogenital haemorrhage:

How the study uses the data?

The study uses data from the FDA. It is based on loratadine (the active ingredients of Claritin) and Claritin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: